Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Denise Beauchemin - My Life is Making a Difference

    ... I wanted to see if I qualified for any of their research studies. After the conference, I was back in the hospital for a third ... to NIH to be evaluated for admission to an eltrombopag clinical trial . There, after another bone marrow biopsy I was diagnosed ...

    Patient Chronicle last updated 04/12/2017 - 7:12am.

  2. Overcoming age barrier to transplantation

    ... over age 50 due to potential complications, dramatic clinical advances have made it possible for older patients to benefit from ... and hematopoietic stem cell transplants. Decades of research, dedication, and hard work by the scientific community have provided ...

    Article last updated 04/03/2017 - 2:00pm.

  3. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

    ... In conclusion, subsets of t-MDS patients with varying clinical outcomes can be identified using conventional risk stratification ...

    Research Article last updated 03/09/2017 - 1:27pm.

  4. Oncologists tell the backstory of informed consent

    ... the farce of informed consent only worsens in medical research. Before you can enroll in a clinical trial of a cancer drug, we’ll hand you a 25-page document that ...

    Article last updated 03/02/2017 - 10:03am.

  5. Drug reduces acute GVHD in unrelated HSCTs

    ... acute GVHD is much more than we expected,” said Henig, a research fellow at the University of Michigan Comprehensive Cancer Center, Ann ... at data for relapse because vorinostat is used in many clinical trials now as an anti-cancer drug. The relapse rate in our short-term ...

    Article last updated 02/27/2017 - 1:45pm.

  6. Advances in antiviral drug cuts infection post SCT

    ... the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and ... and the Center for International Blood and Marrow Transplant Research (CIBMTR) in Orlando, Florida, February 22, 2017. The study, which ...

    Article last updated 02/23/2017 - 7:26am.

  7. Delva Deauna-Limayo, MD

    ... Position / Title:  Clinical Professor Institution:  ... about patient and trainee education, as well as conducting research in hematologic cancers.  ...

    Bio last updated 03/22/2017 - 2:45pm.

  8. New study hails test to weigh SCT for MDS

    ... that is likely to produce the best results, according to new research by scientists at Dana-Farber Cancer Institute and Brigham and ... – based on the genetic profile of the disease and certain clinical factors – to identifying patients for whom a transplant is ...

    Article last updated 02/09/2017 - 9:03am.

  9. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium

    ... In conclusion, subsets of t-MDS patients with varying clinical outcomes can be identified using conventional risk stratification ...

    Research Article last updated 02/03/2017 - 10:09am.

  10. Medical “Must-See” TV in May

    ... 10: the largest hospital in the world devoted solely to research. Inside, our country’s most brilliant scientific minds carry out ... an elemental level and at our most profound.” "The NIH Clinical Center’s more than 60-year history has resulted in remarkable ...

    Article last updated 02/02/2017 - 9:48am.